Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Osada, H., Koshino, H., Isono, K., Takahashi, H. & Kawanishi, G. Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor. J. Antibiot. 44, 259–261 (1991).
Takahashi, H. et al. Reveromycins, new inhibitors of eukaryotic cell growth. II. Biological activities. J. Antibiot. 45, 1414–1419 (1992).
Cui, Z., Hirata, D., Tsuchiya, E., Osada, H. & Miyakawa, T. The multidrug resistance-associated protein (MRP) subfamily (Yrs/Yor1) of Saccharomyces cerevisiae is important for the tolerance to a broad range of organic anions. J. Biol. Chem. 271, 14712–14716 (1996).
Takahashi, H. et al. Inhibitory action of reveromycin A on TGF-α-dependent growth of ovarian carcinoma BG-1 in vitro and in vivo. Oncol. Res. 9, 7–11 (1997).
Miyamoto, Y. et al. Identification of Saccharomyces cerevisiae isoleucyl-tRNA synthetase as a target of the G1-specific inhibitor Reveromycin A. J. Biol. Chem. 277, 28810–28814 (2002).
Tanaka, Y. et al. Reveromycin A inhibits antigen receptor-mediated antigen presentation by B lymphoma cell via its effect on intracellular trafficking of the antigen. J. Antibiot. 55, 904–913 (2002).
Muguruma, H. et al. Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity. Clin. Cancer Res. 11, 8822–8828 (2005).
Woo, J.-T. et al. Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts. Proc. Natl Acad. Sci. USA 103, 4729–4734 (2006).
Yano, A. et al. Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone. Proc. Natl Acad. Sci. USA 105, 15541–15546 (2008).
Hiraoka, K. et al. Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages. Cancer Sci. 99, 1595–1602 (2008).
Takahashi, S. et al. Reveromycin A biosynthesis uses RevG and RevJ for stereospecific spiroacetal formation. Nat. Chem. Biol. 7, 461–468 (2011).
Koshino, H., Takahashi, H., Osada, H. & Isono, K. Reveromycins, new inhibitors of eukaryotic cell growth III. Structure of reveromycins A, B, C, and D. J. Antibiot. 45, 1420–1427 (1992).
Ohtani, I., Kusumi, T., Kashman, Y. & Kakisawa, H. High-Field FT NMR application of Mosher’s method. The absolute configurations of marine terpenoids. J. Am. Chem. Soc. 113, 4092–4096 (1991).
Ubukata, M., Koshino, H., Osada, H. & Isono, K. Absolute configuration of reveromycin A, an inhibitor of the signal transduction of epidermal growth factor. J. Chem. Soc., Chem. Commun. 1877–1878 (1994).
Höltzel, A., Kempter, C., Metzger, J. W. & Jung, G. Spirofungin, a new antifungal antibiotic from Streptomyces violaceusniger Tü 4113. J. Antibiot. 51, 699–707 (1998).
Shimizu, T., Kusaka, J., Ishiyama, H. & Nakata, T. Efficient synthesis of 6,6-spiroacetal of spirofungin A. Tetrahedron Lett. 44, 4965–4968 (2003).
Zanatta, S. D., White, J. M. & Rizzacasa, M. A. Total synthesis of the proposed structure for spirofungin B: a reassignment of the stereochemistry. Org. Lett. 6, 1041–1044 (2004).
Shimizu, T., Satoh, T., Murakoshi, K. & Sodeoka, M. Asymmetric total synthesis of (-)-spirofungin A and (+)-spirofungin B. Org. Lett. 7, 5573–5576 (2005).
Acknowledgements
We thank Ms H. Aono and Ms A. Okano for biological activity tests. This work was supported in part by the Target Protein Research Program, a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry and Health, and Labour Sciences Research Grant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on The Journal of Antibiotics website
Supplementary information
Rights and permissions
About this article
Cite this article
Nogawa, T., Takahashi, S., Sekiyama, Y. et al. Creation of novel reveromycin derivatives by alcohol-added fermentation. J Antibiot 66, 247–250 (2013). https://doi.org/10.1038/ja.2012.115
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ja.2012.115
Keywords
This article is cited by
-
Studies on Streptomyces sp. SN-593: reveromycin biosynthesis, β-carboline biomediator activating LuxR family regulator, and construction of terpenoid biosynthetic platform
The Journal of Antibiotics (2022)
-
Chemical and biological studies of reveromycin A
The Journal of Antibiotics (2016)